Category Specific RSS

asx pyc

PYC Therapeutics receives Orphan Drug Designation for ADOA treatment

PYC Therapeutics (ASX: PYC), a clinical-stage biotechnology company, has achieved a significant milestone with the U.S. Food and Drug Administration…

1 year ago

All eyes on PYC as it doses first patient for eye disease trial

Eye health has been in and out of sight and mind for some time now, urging organisations to demand greater…

2 years ago

PYC gets FDA clearance to kick off human trials for its investigative drug combatting blindness

Genetic eye problems affect over two million people worldwide and often lead to blindness among the working-age population. Though there’s…

2 years ago